LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes-Reference-Cited by-同舟云学术

LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes

Published:2017-05 Issue:5 Volume:12 Page:814-823
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

He Yayi,Yu Hui,Rozeboom Leslie,Rivard Christopher J.,Ellison Kim,Dziadziuszko Rafal,Suda Kenichi,Ren Shengxiang,Wu Chunyan,Hou Likun,Zhou Caicun,Hirsch Fred R.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference75 articles.

1. Lung cancer incidence and mortality in China, 2009;Chen;Thorac Cancer,2013

2. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells;Walker;Clin Cancer Res,2004

3. Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study;Giaccone;Clin Cancer Res,2006

4. New treatment options for ALK-rearranged non-small cell lung cancer;Cameron;Curr Treat Options Oncol,2015

5. Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802);Zhou;Ann Oncol,2015

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissociation of LAG-3 inhibitory cluster from TCR microcluster by immune checkpoint blockade;Frontiers in Immunology;2024-08-21

2. Expression of immune checkpoint molecules TIGIT and TIM-3 by tumor-infiltrating lymphocytes predicts poor outcome in sinonasal mucosal melanoma;Pathology - Research and Practice;2024-08

3. Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions;Immuno;2024-07-05

4. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities;Signal Transduction and Targeted Therapy;2024-05-22

5. LAG‐3 : recent developments in combinational therapies in cancer;Cancer Science;2024-05-04